Pelvic perfusion for advanced colorectal cancers

被引:9
作者
Begossi, Giovanni [1 ,2 ]
Belliveau, James F. [1 ]
Wanebo, Harold J. [1 ,3 ]
机构
[1] Boston Univ, Sch Med, Roger Williams Med Ctr, Providence, RI 02908 USA
[2] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[3] Landmark Med Ctr, Woonsocket, RI USA
关键词
D O I
10.1016/j.soc.2008.04.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Isolated pelvic perfusion (IPP) is a form of intra-arterial local-regional treatment of tumor-bearing organs. IPP using a simplified balloon occlusion technique has shown promise in palliation of resectability of advanced rectal cancer in patients not amenable to treatment with conventional chemoradiation. This article reviews technique criteria and the response to IPP from seven literature studies of isolated pelvic perfusion with colorectal cancer. Current efforts should be directed to improving anti-tumor responses by optimizing chemotherapeutic protocols and modifying perfusion parameters, so that hopefully, this will lead to a more standardized and improved procedure for the isolated pelvic perfusion technique.
引用
收藏
页码:825 / +
页数:20
相关论文
共 50 条
  • [41] Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer
    Turley, R. S.
    Czito, B. G.
    Haney, J. C.
    Tyler, D. S.
    Mantyh, C. R.
    Migaly, J.
    TECHNIQUES IN COLOPROCTOLOGY, 2013, 17 (01) : 95 - 100
  • [42] Intraoperative pelvic brachytherapy for treatment of locally advanced or recurrent colorectal cancer
    R. S. Turley
    B. G. Czito
    J. C. Haney
    D. S. Tyler
    C. R. Mantyh
    J. Migaly
    Techniques in Coloproctology, 2013, 17 : 95 - 100
  • [43] Surgical results of total pelvic exenteration for locally advanced colorectal adenocarcinorna
    Takeuchi, H
    Ueo, H
    Haraoka, M
    Muehara, Y
    HEPATO-GASTROENTEROLOGY, 2005, 52 (61) : 90 - 93
  • [44] Monoclonal antibodies in cancers - Monoclonal antibodies in the therapy of advanced colorectal cancer
    Schalhorn, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2005, 55 (11): : 709 - 710
  • [45] Mutational analysis of the BAK gene in 192 advanced gastric and colorectal cancers
    Sakamoto, I
    Yamada, T
    Ohwada, S
    Koyama, T
    Nakano, T
    Okabe, T
    Hamada, K
    Kawate, S
    Takeyoshi, I
    Iino, Y
    Morishita, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (01) : 53 - 55
  • [46] Outcomes of pelvic exenteration for recurrent or primary locally advanced colorectal cancer
    Yang, Hwa Yeon
    Park, Sung Chan
    Hyun, Jong Hee
    Seo, Ho Kyung
    Oh, Jae Hwan
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2015, 89 (03) : 131 - 137
  • [47] Can quantitative iodine parameters on DECT replace perfusion CT parameters in colorectal cancers?
    Kang, Hyo-Jin
    Kim, Se Hyung
    Bae, Jae Seok
    Jeon, Sun Kyung
    Han, Joon Koo
    EUROPEAN RADIOLOGY, 2018, 28 (11) : 4775 - 4782
  • [48] ADJUVANT PORTAL LIVER PERFUSION IN COLORECTAL CANCERS - A SWISS MULTI-CENTER STUDY
    METZGER, U
    AEBERHARD, P
    EGELI, RA
    HARDER, F
    LARGIADER, F
    MULLER, W
    PETTAVEL, J
    WEBER, W
    CAVALLI, F
    HELVETICA CHIRURGICA ACTA, 1982, 49 (1-2) : 175 - 178
  • [49] Can quantitative iodine parameters on DECT replace perfusion CT parameters in colorectal cancers?
    Hyo-Jin Kang
    Se Hyung Kim
    Jae Seok Bae
    Sun Kyung Jeon
    Joon Koo Han
    European Radiology, 2018, 28 : 4775 - 4782
  • [50] Management of locally advanced synchronous colorectal and prostate cancers A case report
    Tey, Yi Qing
    Ravi, Kavimalar
    Chong, Choon Seng
    Chiong, Edmund
    Ho, Jingshan
    Tey, Jeremy Chee Seong
    Ho, Francis
    MEDICINE, 2020, 99 (22) : E20336